SE9103837D0 - Fluorescensdiagnostik av cancer utnyttjande delta-aminolevulinsyra - Google Patents
Fluorescensdiagnostik av cancer utnyttjande delta-aminolevulinsyraInfo
- Publication number
- SE9103837D0 SE9103837D0 SE9103837A SE9103837A SE9103837D0 SE 9103837 D0 SE9103837 D0 SE 9103837D0 SE 9103837 A SE9103837 A SE 9103837A SE 9103837 A SE9103837 A SE 9103837A SE 9103837 D0 SE9103837 D0 SE 9103837D0
- Authority
- SE
- Sweden
- Prior art keywords
- tissue
- cancer
- delta
- fluorescense
- diagnosis
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000005284 excitation Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 238000010253 intravenous injection Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 abstract 1
- 239000000439 tumor marker Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0091—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for mammography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems
- A61B5/4306—Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
- A61B5/4312—Breast evaluation or disorder diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9103837A SE9103837L (sv) | 1991-12-21 | 1991-12-21 | Fluorescensdiagnostik av cancer utnyttjande delta- aminolevulinsyra |
PCT/SE1992/000879 WO1993013403A1 (en) | 1991-12-21 | 1992-12-18 | FLUORESCENCE DIAGNOSTICS OF CANCER USING δ-AMINO LEVULINIC ACID |
EP19930901458 EP0588994A1 (en) | 1991-12-21 | 1993-07-19 | FLUORESCENCE DIAGNOSTICS OF CANCER USING $g(d)-AMINO LEVULINIC ACID |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9103837A SE9103837L (sv) | 1991-12-21 | 1991-12-21 | Fluorescensdiagnostik av cancer utnyttjande delta- aminolevulinsyra |
Publications (2)
Publication Number | Publication Date |
---|---|
SE9103837D0 true SE9103837D0 (sv) | 1991-12-21 |
SE9103837L SE9103837L (sv) | 1993-06-22 |
Family
ID=20384715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9103837A SE9103837L (sv) | 1991-12-21 | 1991-12-21 | Fluorescensdiagnostik av cancer utnyttjande delta- aminolevulinsyra |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0588994A1 (sv) |
SE (1) | SE9103837L (sv) |
WO (1) | WO1993013403A1 (sv) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2226544A1 (en) * | 1995-07-12 | 1997-01-30 | Hisao Takayanagi | 2,2-dideutero-5-aminolevulinic acid |
DE29620732U1 (de) * | 1995-09-26 | 1997-04-24 | Storz Karl Gmbh & Co | Vorrichtung zur photodynamischen Diagnose |
ZA967500B (en) * | 1995-12-21 | 1998-03-05 | Unilever Plc | Device for the identification of acne, microcomedones, and bacteria on human skin. |
DE19618963C5 (de) * | 1996-05-10 | 2004-01-22 | Stepp, Herbert, Dr. | Zusatzvorrichtung für ein Endoskop und Verfahren zur endoskopischen Erfassung von Fluoreszenzlicht unter Verwendung derselben |
SE507490C2 (sv) * | 1996-08-27 | 1998-06-15 | Medeikonos Ab | Förfarande för detektering av cancer i hud på människor och däggdjur samt anordning för utövande av förfarandet |
US6989140B2 (en) | 2001-12-21 | 2006-01-24 | Threshold Pharmaceuticals, Inc. | Methods for cancer imaging |
WO2004083944A2 (en) | 2003-03-18 | 2004-09-30 | The General Hospital Corporation | Polarized light devices and methods |
WO2005027730A2 (en) | 2003-09-19 | 2005-03-31 | The General Hospital Corporation | Fluorescence polarization imaging devices and methods |
CZ301399B6 (cs) * | 2004-09-03 | 2010-02-17 | Stabilizacní disperzní základ pro fotodynamickou diagnostiku a terapii | |
EP1742038A1 (en) * | 2005-07-06 | 2007-01-10 | Academisch Medisch Centrum bij de Universiteit van Amsterdam | Device and method for determining the concentration of a substance |
EP2318823B1 (en) | 2008-08-15 | 2015-12-02 | Erasmus University Medical Center Rotterdam | Methods and devices for assessment of mitochondrial function |
KR20140039030A (ko) * | 2011-06-29 | 2014-03-31 | 교토후고리츠다이가쿠호진 | 종양 부위의 식별 장치 및 식별 방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE455646B (sv) * | 1984-10-22 | 1988-07-25 | Radians Innova Ab | Fluorescensanordning |
GB2203831B (en) * | 1986-07-07 | 1991-02-06 | Academy Of Applied Sciences | Apparatus and method for the diagnosis of malignant tumours |
SE8900612D0 (sv) * | 1989-02-22 | 1989-02-22 | Jonas Johansson | Vaevnadskarakterisering utnyttjande ett blodfritt fluorescenskriterium |
US5079262A (en) * | 1989-07-28 | 1992-01-07 | Queen's University At Kingston | Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid |
-
1991
- 1991-12-21 SE SE9103837A patent/SE9103837L/sv not_active Application Discontinuation
-
1992
- 1992-12-18 WO PCT/SE1992/000879 patent/WO1993013403A1/en not_active Application Discontinuation
-
1993
- 1993-07-19 EP EP19930901458 patent/EP0588994A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1993013403A1 (en) | 1993-07-08 |
EP0588994A1 (en) | 1994-03-30 |
SE9103837L (sv) | 1993-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dougherty et al. | Photoradiation therapy—clinical and drug advances | |
SE9103837D0 (sv) | Fluorescensdiagnostik av cancer utnyttjande delta-aminolevulinsyra | |
ATE194916T1 (de) | Intraoperative, intravaskulare und endoskopische bestimmung und behandlung von verletzungen und tumoren | |
FI923743A0 (fi) | Med ultraljud effektiverat foerfarande foer levererande av materialer genom huden. | |
Kessel et al. | Porphyrin accumulation by atheromatous plaques of the aorta | |
FI955336A (sv) | Tricyklopolyazamakrocyklofosfonsyror, komplex och derivat därav för användning som kontrasmedel | |
FI955319A0 (sv) | 2-pyridylmetylenpolyazamakrocyklofosfonsyror, komplexer och derivat av dessa för användning som kontrastmedel | |
EA200401410A1 (ru) | Фармацевтическая композиция | |
DE69014137D1 (de) | Immunogenische Zusammensetzungen gegen Gastrin-Peptide. | |
CY1106860T1 (el) | Δομες χρωστικων ευαισθητες σε οξεα και διασπωμενες ενζυμικα για τη διαγνωστικη με ακτινοβολια εγγυς υπερυθρου και για τη θεραπεια | |
EA199900695A1 (ru) | Проникновение анестезирующих средств для местного воздействия, осуществляемое с помощью лазера | |
ATE7856T1 (de) | Gamma-linolensaeuren enthaltende pharmazeutische und diaetetische zusammensetzung. | |
DE69813553D1 (de) | Anwendung von akustooptischen und sonolumineszenten kontrastmitteln in diagnostischen verfahren | |
NZ334191A (en) | Method for improved selectivity in photo-activation and detection of molecular diagnostic agents | |
PT1157041E (pt) | Anticorpos para terapia e diagnostico de cancro | |
RU92016479A (ru) | Применение 5,10,15,20-тетракис (4-карбоксифенил) порфина для обнаружения и лечения рака легких | |
DE69826711D1 (de) | Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie | |
IT8021498A0 (it) | Sali misti di amminoacidi essenziali o semi-essenziali e loro analoghi non azotati, nonche' loro impiego nella terapia di disfunzioni renali ed epatiche. | |
FR2373599A1 (fr) | Luminophore perfectionne a base d'oxyhalogenure de terres-rares | |
ATE161419T1 (de) | Kosmetische zusammensetzung, die einen lipidstoff und eine hydroxy - oder ketofettsäure enthält | |
SE8401537D0 (sv) | Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande ibuprofen och sett att anvenda dessa | |
DE3484198D1 (de) | Verfahren zur erhoehung der zielspezifizitaet in antikoerperbestimmungen und zur raeumung von nichtzielspezifischen diagnostischen und therapeutischen faktoren. | |
FI895141A0 (fi) | Kelatmedel med orto-ligerande funktionalitet och deras komplexer. | |
SE7902742L (sv) | Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav | |
FI913391A0 (fi) | Foerfarande foer detektering av smaocellcarcinom och anvaendning av acylpeptidhydrolas och denna kodande sekvenser. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 9103837-2 Format of ref document f/p: F |